Loss of the PTCH1 tumor suppressor defines a new subset of plexiform fibromyxoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1479-5876
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Loss of the PTCH1 tumor suppressor defines a new subset of plexiform fibromyxoma ; volume:17 ; number:1 ; day:30 ; month:7 ; year:2019 ; pages:1-8 ; date:12.2019
Journal of translational medicine ; 17, Heft 1 (30.7.2019), 1-8, 12.2019
- Urheber
-
Banerjee, Sudeep
Corless, Christopher L.
Miettinen, Markku M.
Noh, Sangkyu
Ustoy, Rowan
Davis, Jessica L.
Tang, Chih-Min
Yebra, Mayra
Burgoyne, Adam M.
Sicklick, Jason K.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12967-019-1995-z
- URN
-
urn:nbn:de:101:1-2019122505403903338756
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Banerjee, Sudeep
- Corless, Christopher L.
- Miettinen, Markku M.
- Noh, Sangkyu
- Ustoy, Rowan
- Davis, Jessica L.
- Tang, Chih-Min
- Yebra, Mayra
- Burgoyne, Adam M.
- Sicklick, Jason K.
- SpringerLink (Online service)
Ähnliche Objekte (12)
ERBB2/HOXB13 co-amplification with interstitial loss of BRCA1 defines a unique subset of breast cancers
Dysregulation of a specific immune-related network of genes biologically defines a subset of schizophrenia
Downregulation of miR-204 expression defines a highly aggressive subset of Group 3/Group 4 medulloblastomas
Large-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancer
Expression of leukosialin (CD43) defines a major intrahepatic T cell subset associated with protective responses in visceral leishmaniasis
Loss of tumor suppressor menin expression in high grade cholangiocarcinomas
A FERM-adjacent (FA) region defines a subset of the 4.1 superfamily and is a potential regulator of FERM domain function
Identification of vestibular loss in children with sensorineural hearing loss using the balance subset of the BOT-2 test
Loss of Tumor Suppressor Gene Function in Human Cancer: An Overview
In vivo pharmacological profiling in Xenopus embryos defines a subset of A1 adenosine receptor-selective antagonists with potent anti-angiogenic activities
Investigation of tumor suppressor gene loss on chromosome 8p in hepatocellular carcinoma
Loss of the candidate tumor suppressor ZEB1 (TCF8, ZFHX1A) in Sézary syndrome
ERBB2/HOXB13 co-amplification with interstitial loss of BRCA1 defines a unique subset of breast cancers
Dysregulation of a specific immune-related network of genes biologically defines a subset of schizophrenia
Downregulation of miR-204 expression defines a highly aggressive subset of Group 3/Group 4 medulloblastomas
Large-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancer
Expression of leukosialin (CD43) defines a major intrahepatic T cell subset associated with protective responses in visceral leishmaniasis
Loss of tumor suppressor menin expression in high grade cholangiocarcinomas
A FERM-adjacent (FA) region defines a subset of the 4.1 superfamily and is a potential regulator of FERM domain function
Identification of vestibular loss in children with sensorineural hearing loss using the balance subset of the BOT-2 test
Loss of Tumor Suppressor Gene Function in Human Cancer: An Overview
In vivo pharmacological profiling in Xenopus embryos defines a subset of A1 adenosine receptor-selective antagonists with potent anti-angiogenic activities
Investigation of tumor suppressor gene loss on chromosome 8p in hepatocellular carcinoma
Loss of the candidate tumor suppressor ZEB1 (TCF8, ZFHX1A) in Sézary syndrome
ERBB2/HOXB13 co-amplification with interstitial loss of BRCA1 defines a unique subset of breast cancers
Dysregulation of a specific immune-related network of genes biologically defines a subset of schizophrenia
Downregulation of miR-204 expression defines a highly aggressive subset of Group 3/Group 4 medulloblastomas
Large-scale analysis of CDH1 mutations defines a distinctive molecular subset with treatment implications in gastric cancer
Expression of leukosialin (CD43) defines a major intrahepatic T cell subset associated with protective responses in visceral leishmaniasis
Loss of tumor suppressor menin expression in high grade cholangiocarcinomas
A FERM-adjacent (FA) region defines a subset of the 4.1 superfamily and is a potential regulator of FERM domain function
Identification of vestibular loss in children with sensorineural hearing loss using the balance subset of the BOT-2 test
Loss of Tumor Suppressor Gene Function in Human Cancer: An Overview
In vivo pharmacological profiling in Xenopus embryos defines a subset of A1 adenosine receptor-selective antagonists with potent anti-angiogenic activities
Investigation of tumor suppressor gene loss on chromosome 8p in hepatocellular carcinoma